JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (6): 696-699.DOI: 10.3969/j.issn.1671-2587.2021.06.004
Previous Articles Next Articles
Received:
2021-06-09
Online:
2021-12-20
Published:
2021-12-21
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2021.06.004
[1] 范思聪,何昕. 高胆红素血症对新生儿肝脏损伤的研究进展[J]. 中国妇幼保健,2019,34(13):3133-3136. [2] HOSSAIN M,BEGUM M,AHMED S,et al.Causes,management and immediate complications of management of neonatal jaundice? A hospital-based study[J]. J Enam Med Col,2015,5(2):104-109. [3] ZAHED PASHA Y,ALIZADEH-TABARI S,ZAHED PASHA E,et al.Etiology and therapeutic management of neonatal jaundice in Iran:a systematic review and meta-analysis[J]. World J Pediatr,2020,16(5):480-493. [4] KAKKAR B,AGRAWAL S,CHOWDHRY M,et al.Exchange transfusion in neonatal hyperbilirubinemia:a single Centre experience from Northern India[J]. Transfus Apher Sci,2019,58(6):102655. [5] BUJANDRIC N,GRUJIC J.Exchange transfusion for severe neonatal hyperbilirubinemia:17 years' experience from Vojvodina,Serbia[J]. Indian J Hematol Blood Transfus,2016,32(2):208-214. [6] BHUTANI V K,JOHNSON L,SIVIERI E M.Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns[J]. Pediatrics,1999,103(1):6-14. [7] 中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志,2014,52(10):745-748. [8] 丁国芳,张苏平,姚丹,等. 正常新生儿黄疸与围产因素的调查[J]. 中华围产医学杂志,2001(2):99-101. [9] TAVAKOLIZADEH R,IZADI A,SEIRAFI G,et al.Maternal risk factors for neonatal jaundice:a hospital-based cross-sectional study in Tehran[J]. Eur J Transl Myol,2018,28(3):7618. [10] 崔花淑,朴爱善. 新生儿高胆红素血症360例病因分析[J]. 中国社区医师(医学专业),2012,14(29):85-86. [11] SGRO M,KANDASAMY S,SHAH V,et al.Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines[J]. J Pediatr,2016,171:43-47. [12] YU C F,LI H F,ZHANG Q N,et al.Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period,from 2001 to 2011[J]. PLoS One,2017,12(6):e0179550. [13] 王晓娇,王亚娟,邵芳,等. 新生儿黄疸换血疗法对新生儿内环境的影响[J]. 首都医科大学学报,2016,37(2):136-140. [14] 吴远军,隗伏冰,杨勇. 胎儿及新生儿免疫溶血性疾病研究进展[J]. 中华围产医学杂志,2020,23(1):44-51. [15] 廉银珠,张聘聘,秦秀娇,等. 胆红素与冠心病关系的研究进展[J]. 中华心血管病杂志,2016,44(1):76-79. [16] DEY S K,ISLAM S,JAHAN I,et al.Association of hyperbilirubinemia requiring phototherapy or exchange transfusion with hearing impairment among admitted term and late preterm newborn in a NICU[J]. Mymensingh Med J,2020,29(2):405-413. [17] 冯霄,童笑梅. 新生儿高胆红素血症光疗不良反应研究进展[J]. 临床儿科杂志,2020,38(9):711-715. [18] 迟春昕,侯海萍,陆丽华,等. 经络抚触对新生儿高胆红素血症患儿治疗依从性和生长发育的影响[J]. 海南医学,2018,29(4):589-592. [19] 赵红梅,关丽婵,石国燕,等. 抚触对新生儿黄疸影响的研究[J]. 中华护理杂志,2003,38(10):772-773. [20] OLUSANYA B O,IMAM Z O,EMOKPAE A A,et al.Revisiting the criteria for exchange transfusion for severe neonatal hyperbilirubinemia in resource-limited settings[J]. Neonatology,2015,109(2):97-104. [21] AMERICAN Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics,2004,114(1):297-316. [22] 唐熙. 新生儿高胆红素血症换血疗法的研究进展[J]. 全科护理,2017,15(18):2211-2213. [23] NEW H V,BERRYMAN J,BOLTON-MAGGS P H B,et al. Guidelines on transfusion for fetuses,neonates and older children[J]. Br J Haematol,2016,175(5):784-828. [24] FERGUSSON D A,HÉBERT P,HOGAN D L,et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature,very low-birth-weight infants:the ARIPI randomized trial[J]. JAMA,2012,308(14):1443-1451. [25] 沈玉才,黄维本,巢伟聪,等. 不同球浆比例换血治疗新生儿重症高胆红素血症的研究[J]. 中国现代医生,2012,50(27):50-51. [26] 杨丽莎,郑显兰,何华云,等. 单双倍血量换血治疗新生儿高胆红素血症的效果研究[J]. 重庆医学,2017,46(19):2618-2620. [27] KIM M S,CHUNG Y,KIM H,et al.Neonatal exchange transfusion:experience in Korea[J]. Transfus Apher Sci,2020,59(3):102730. [28] 朱淑贞,徐红贞,周莲娟,等. 新生儿重度高胆红素血症行换血治疗后不良反应及结局特点分析[J]. 护理与康复,2020,19(1):28-32. |
[1] | ZHANG Rong, WANG Wen-ting, GU Shun-li, et al. Discussion on Monitoring Process and Blood Transfusion Strategy of Passenger Lymphocyte Syndrome [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 681-685. |
[2] | WANG Qian, YANG Li-hui, DING Tian-ling, et al. Clinical Analysis of Platelet Transfusion for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Different Conditioning Regimens [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 686-692. |
[3] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 693-695. |
[4] | FU Xiao-yan, ZHANG shuai-hang, SHAO hua, et al. Impact of Erythrocyte Storage Duration on Blood Indexes in Children with Open Heart Surgery by Cardiopulmonary Bypass [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 700-703. |
[5] | QIU Li-juan, FU Xiao-yan, GUO Kai, et al. Analysis of Antibody Titers of 60 Pediatric Patients with Strong Positive Platelet Antibody Screening Results [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 704-707. |
[6] | WANG Cui-e, LIU Zhi-wei, KONG Chang-hong, et al. Establishment and Application of Clinical Transfusion Service Information Platform [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 715-718. |
[7] | JING Yuan-yuan, WANG Jie, LI Dong-mei, et al. Factors Influencing Development of HLA and/or HPA Antibodies in Patients with Platelet Refractoriness [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 723-727. |
[8] | MA Ting, NIU Jia-meng, CHEN Xin-yue, et al. Analysis of Blood Transfusion in 8 053 Hospitalized Deceased Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 732-736. |
[9] | WANG Rui-han, LIU Hao, LIU Pei, et al. Indication of Intraoperative Cell Salvage in Cesarean Section [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 742-745. |
[10] | MA Ling, WU Min-hui, ZHAO Fang, et al. The Genotyping and Alloimmunization Study of RhD among Perinatal Women with RhD Initial Typing Negative [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 746-749. |
[11] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 794-796. |
[12] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 800-802. |
[13] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 803-805. |
[14] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 806-810. |
[15] | HU Yan, ZHU Bang-qiang, WEN Hui-qin, et al. Lymphoplasmapheresis in ABO-incompatible Living Donor Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(5): 608-611. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||